Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia. (Record no. 12247123)

MARC details
000 -LEADER
fixed length control field 00815 a2200205 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514052117.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200211s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1362-0347
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/ebmh.5.4.113
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Marois, Marie-Josée
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20021120
245 00 - TITLE STATEMENT
Title Haloperidol decanoate doses of 200, 100, or 50 mg/month reduced symptomatic exacerbations more than a 25 mg/month dose in schizophrenia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Evidence-based mental health
Date of publication, distribution, etc. Nov 2002
300 ## - PHYSICAL DESCRIPTION
Extent 113 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comment; Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roy, Marc-André
773 0# - HOST ITEM ENTRY
Title Evidence-based mental health
Related parts vol. 5
-- no. 4
-- p. 113
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/ebmh.5.4.113">https://doi.org/10.1136/ebmh.5.4.113</a>
Public note Available from publisher's website

No items available.